Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101

University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Medical Physics (Impact Factor: 2.64). 08/2010; 37(8):4078-101. DOI: 10.1118/1.3438081
Source: PubMed


Task Group 101 of the AAPM has prepared this report for medical physicists, clinicians, and therapists in order to outline the best practice guidelines for the external-beam radiation therapy technique referred to as stereotactic body radiation therapy (SBRT). The task group report includes a review of the literature to identify reported clinical findings and expected outcomes for this treatment modality. Information is provided for establishing a SBRT program, including protocols, equipment, resources, and QA procedures. Additionally, suggestions for developing consistent documentation for prescribing, reporting, and recording SBRT treatment delivery is provided.

  • Source
    • "Cabe destacar que en ninguno de los casos, la dosis recibida por losórganos sanos fue superior a la dosis de tolerancia dé estos para tratamientos dé unica sesión (Tabla 1), punto decisivo y en extremo importante , en cuanto a prevención de efectos determinísticos y estocásticos en el paciente [11] [12] [13] [14] [15] [16] [17] [18] [19]. El comportamiento deí ındice de conformación, respecto al volumen de la lesión, puede observarse en la figura 4. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Resumen Se estudió la aplicación de la técnica VMAT (Radioterapia de Intensidad Modulada en Arcos) con colimador de 120 láminas, para la implementación de esta técnica como alternativa a la radiocirugía estereotáctica. Para ello se realizaron planes de tratamiento (simulaciones) bajo técnica VMAT, mediante planificación inversa y la posterior verificación (medición) física de los planes a 10 pacientes con múltiples metástasis cerebrales y tumor primario controlado, encontrándose un aceptablé ındice de conformación para esta modalidad (comparable a los de radiocirugía) en lesiones mayores a 1,5cm, así como dosis de radiación en losórganos sanos por debajo de las dosis límites de tolerancia en todos los casos. Palabras Clave: IMRT, VMAT, Metastasis Cerebrales, Radiocirugía. Abstract It was studied the application of VMAT technique (Volumetric Modulated Arc Therapy) with a multileaf collimator of 120 leafs, for implementation of this technique as an alternative to stereotactic radiosurgery. To achieve this goal, treatment plans (simulations) were made under VMAT technique using inverse planning and furthermore the physical verification of these plans to 10 patients with multiple brain metastases and primary tumor controlled, finding an acceptable conformation index for this modality (comparable to radiosurgery) in lesions with 1,5cm or more. The doses of radiation in the healthy organs were below the tolerance dose in all cases.
    Full-text · Article · Aug 2015
  • Source
    • "While differences in treatment capabilities exist in the various lung SABR delivery platforms, a systematic review found no differences in overall survival for ES-NSCLC when using different technologies [83]. Published guidelines in both North America [84] [85] [86] and the European Union [47] [87] have supported institutional credentialing procedures, standardization of normal tissue tolerances, and increased discourse on the use of SABR in a multidisciplinary setting. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer is growing rapidly, particularly since it has become the recommended therapy for unfit patients in current European and North American guidelines. As three randomized trials comparing surgery and SABR closed prematurely because of poor accrual, clinicians are faced with a dilemma in individual patient decision-making. Radiation oncologists, in particular, should be aware of the data from comparative effectiveness studies that suggest similar survival outcomes irrespective of local treatment modality. The necessity of obtaining a pathological diagnosis, particularly in frail patients prior to treatment remains a challenge, and this topic was addressed in recent European recommendations. Awareness of the high incidence of a second primary lung cancer in survivors, as well as other competing causes of mortality, is needed. The challenges in distinguishing focal scarring from recurrence after SABR also need to be appreciated by multidisciplinary tumor boards. With a shift in focus toward patient-centered decision-making, clinicians will need to be aware of these new developments and communicate effectively with patients, to ensure that treatment decisions are reflective of patient preferences. Priorities for additional research in the area are proposed. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
    Full-text · Article · Dec 2014 · Radiotherapy and Oncology
  • Source
    • "Common criteria chosen to evaluate the treatment plans were taken from the National Comprehensive Cancer Network (NCCN) guidelines for Non-small cell lung cancer [21], Timmerman et al. [22], and AAPM task group no. 101 report on SABR for lung cancer [23]. The constraints adopted to accept a treatment plan were: "
    [Show abstract] [Hide abstract]
    ABSTRACT: Boron Neutron Capture Therapy (BNCT) is a radiotherapy that combines biological targeting and high LET radiation. It consists in the enrichment of tumour with (10)B and in the successive irradiation of the target with low energy neutrons producing charged particles that mainly cause non-repairable damages to the cells. The feasibility to treat Non Small Cells Lung Cancer (NSCLC) with BNCT was explored. This paper proposes a new approach to determine treatment plans, introducing the possibility to choose the irradiation start and duration to maximize the tumour dose. A Tumour Control Probability (TCP) suited for lung BNCT as well as other high dose radiotherapy schemes was also introduced. Treatment plans were evaluated in localized and disseminated lung tumours. Semi-ideal and real energy spectra beams were employed to assess the best energy range and the performance of non-tailored neutron sources for lung tumour treatments. The optimal neutron energy is within [500 eV-3 keV], lower than the 10 keV suggested for the treatment of deep-seated tumours in the brain. TCPs higher than 0.6 and up to 0.95 are obtained for all cases. Conclusions drawn from [Suzuki et al., Int Canc Conf J 1 (4) (2012) 235-238] supporting the feasibility of BNCT for shallow lung tumours are confirmed, however discussions favouring the treatment of deeper lesions and disseminated disease are also opened. Since BNCT gives the possibility to deliver a safe and potentially effective treatment for NSCLC, it can be considered a suitable alternative for patients with few or no treatment options.
    Full-text · Article · Aug 2014 · Physica Medica
Show more